Clinical Trial

A First-In-Man Study to Assess Safety and Efficacy of Ultra High Pressure PTA Balloon ULTRAVIOLET in Treating A-V Fistula Stenosis

Study acronym: ULTRAVIOLETFIM
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
First-In-Man Single Arm Prospective Study to assess the safety and efficacy of ULTRAVIOLET UHP PTA balloon.
Trial Details
NCT Number NCT07330817
Lead Sponsor Cardionovum GmbH
Conditions Arterio-venous Fistula, Stenosis of Arteriovenous Dialysis Fistula
Enrollment 35 participants
Start Date 2026-02
Primary Completion 2027-01 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-01-09